General Information of Drug (ID: DMU49JN)

Drug Name
(R)-N2-{4-[(3-fluorobenzyl)oxy]benzyl}alaninamide Drug Info
Synonyms
CHEMBL82327; 174756-44-6; (R)-2-((4-((3-Fluorobenzyl)oxy)benzyl)amino)propanamide; AC1NUPG0; SCHEMBL194169; CHEBI:94774; BDBM50080950; ZINC26506755; AKOS030631890; AN-31998; BRD-K84639753-066-01-9; (R)-2-(4-(3-fluorobenzyloxy)benzylamino)propanamide
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
5487407
ChEBI ID
CHEMBL94774
TTD Drug ID
DMU49JN

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Monoamine oxidase type B (MAO-B) TTGP7BY AOFB_HUMAN Inhibitor [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Monoamine oxidase type B (MAO-B) DTT MAOB 9.367 6.907 8.237 8.409
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Monoamine oxidase type B (MAO-B) DTT MAOB 2.65E-02 1.12E-02 0.07
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoa... J Med Chem. 2007 Oct 4;50(20):4909-16.